Skip to main content
Start of content

HESA Committee Meeting

Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at

Previous day publication Next day publication

Notice of meeting Amended

Standing Committee on Health (HESA)
42nd Parliament, 1st Session
Meeting 112
Thursday, September 27, 2018, 8:45 a.m. to 10:45 a.m.

8:45 a.m. to 9:00 a.m.
(In Camera)Amended


9:00 a.m. to 9:45 a.m.
Department of Health
• Catherine Parker, Director General, Biologics and Genetic Therapies Directorate, Health Products and Food Branch
• Karen Reynolds, Executive Director, Office of Pharmaceuticals Management Strategies
• Dr. John Patrick Stewart, Director General, Therapeutic Products Directorate

9:45 a.m. to 10:45 a.m.
Amyotrophic Lateral Sclerosis Society of Canada
• Tammy Moore, Chief Executive Officer
Canadian Organization for Rare Disorders
• Maureen Smith, Board Secretary
• Durhane Wong-Rieger, President and Chief Executive Officer
Clerk of the Committee
Marie-Hélène Sauvé (613-995-4108)
2018-09-26 2:08 p.m.